UK regulator weighs whether AI scribes are medical devices

Bulletin

The Specola’s log records a dispatch from STAT News, dated August 4th, concerning the United Kingdom’s Medicines and Healthcare products Regulatory Agency and its ongoing deliberation over AI scribes, software tools that listen to clinical encounters and generate documentation for physicians. The STAT Health Tech edition frames the question plainly: are these listening-and-writing tools medical devices under UK law, or something else entirely.

The dispatch does not resolve the question. It reports the regulator weighing the matter, with implications for how such tools might be classified, reviewed, and monitored going forward. A determination either way would set terms for oversight across the sector, since device status typically brings safety and efficacy requirements that other software categories escape.

The same STAT edition carries a second item of note. The US Centers for Medicare and Medicaid Services has eliminated key payment pathways previously available to devices holding “breakthrough” designation, a change affecting how newly designated technologies reach patients and secure reimbursement in the American system.

No further detail on either matter is available in the material at hand. The Specola notes both items as under active regulatory consideration, with outcomes pending on both sides of the Atlantic, and will record developments as they reach the log.